| APAP | Acetaminophen |
| APCs | Antigen presenting cells |
| Bg | Beige mutation |
| CVDs | Cardiovascular diseases |
| ECM | Extracellular matrix |
| FDA | Food and Drug Administration |
| Gas6 | Growth arrest-specific 6 |
| HCV | Hepatitis C virus |
| HSCs | Hepatic stellate cells |
| IFN | Interferon |
| ILDs | Interstitial lung diseases |
| IPF | Idiopathic pulmonary fibrosis |
| I/R | Ischemia/reperfusion |
| KO | Knock-out |
| MFBs | Myofibroblastic cells |
| NAFLD | Non-alcoholic fatty liver disease |
| ProS | Protein S |
| SCID | Severe combined immunodeficiency |
| TAM | Tyro3, Axl, MerTK |
| TGF-β | Transforming growth factor beta |
| TLR | Toll-like receptor |
| VSMCs | Vascular smooth muscle cells |